Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1991 1
1992 1
1993 1
1998 4
2000 2
2002 3
2003 2
2004 2
2005 7
2006 9
2007 11
2008 9
2009 16
2010 29
2011 23
2012 34
2013 42
2014 31
2015 37
2016 38
2017 34
2018 51
2019 73
2020 66
2021 78
2022 73
2023 69
2024 52
2025 91
2026 30

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

801 results

Results by year

Filters applied: . Clear all
Page 1
Adult Phenotype of CHD2-Associated Disorders.
Rong M, Zulfiqar Ali Q, Aledo-Serrano A, Bayat A, Devinsky O, Qaiser F, Chandran I, Ali A, Fasano A, Bassett AS, Andrade DM. Rong M, et al. Neurol Genet. 2024 Nov 25;10(6):e200194. doi: 10.1212/NXG.0000000000200194. eCollection 2024 Dec. Neurol Genet. 2024. PMID: 39601014 Free PMC article.
RESULTS: In this prospective study, 14 unrelated adult patients (age range: 18-45 years, median: 21 years) with LP/P CHD2 variants were described. Eleven novel variants were identified. No genotype-phenotype correlations were identified. 79% of adults still have ongoing se …
RESULTS: In this prospective study, 14 unrelated adult patients (age range: 18-45 years, median: 21 years) with LP/P CHD2 variants we …
Integrative analyses highlight functional regulatory variants associated with neuropsychiatric diseases.
Guo MG, Reynolds DL, Ang CE, Liu Y, Zhao Y, Donohue LKH, Siprashvili Z, Yang X, Yoo Y, Mondal S, Hong A, Kain J, Meservey L, Fabo T, Elfaki I, Kellman LN, Abell NS, Pershad Y, Bayat V, Etminani P, Holodniy M, Geschwind DH, Montgomery SB, Duncan LE, Urban AE, Altman RB, Wernig M, Khavari PA. Guo MG, et al. Nat Genet. 2023 Nov;55(11):1876-1891. doi: 10.1038/s41588-023-01533-5. Epub 2023 Oct 19. Nat Genet. 2023. PMID: 37857935 Free PMC article.
Clinical and Neurodevelopmental Characteristics of Paralogous Gain-of-Function Variants at GRIA2 p.Gly792 and GRIA3 p.Gly803.
Sjøstrøm E, Studniarczyk D, Dou X, Dahl RS, Cruz V, Wang H, Mercier S, Deb W, Besnard T, Friedman J, Essid M, Karoui S, Jemaa LB, Benyounes T, Lesca G, Tonduti D, Iascone M, Orcesi S, Fradin M, Dubourg C, Napuri S, Cull-Candy SG, Coombs ID, Farrant M, Bayat A. Sjøstrøm E, et al. Clin Genet. 2025 Nov;108(5):553-565. doi: 10.1111/cge.14770. Epub 2025 May 20. Clin Genet. 2025. PMID: 40391499 Free PMC article.
We recruited nine unrelated patients with either known disease-causing GOF variants in GRIA3 at position p.Gly803 or variants at the paralogous position in GRIA2 (p.Gly792). Specifically, five patients carried a de novo GRIA3 variant (p.Gly803Glu or p. …
We recruited nine unrelated patients with either known disease-causing GOF variants in GRIA3 at position p.Gly803 or variants at the …
Adult Phenotype of SYNGAP1-DEE.
Rong M, Benke T, Zulfiqar Ali Q, Aledo-Serrano Á, Bayat A, Rossi A, Devinsky O, Qaiser F, Ali AS, Fasano A, Bassett AS, Andrade DM. Rong M, et al. Neurol Genet. 2023 Nov 17;9(6):e200105. doi: 10.1212/NXG.0000000000200105. eCollection 2023 Dec. Neurol Genet. 2023. PMID: 38045990 Free PMC article.
METHODS: Patients 18 years or older with DEE carrying likely pathogenic and pathogenic (LP/P) SYNGAP1 variants were recruited through physicians' practices and patient organization groups. ...RESULTS: Fourteen unrelated adult patients (median: 21 years, range: 18-65 years) …
METHODS: Patients 18 years or older with DEE carrying likely pathogenic and pathogenic (LP/P) SYNGAP1 variants were recruited through …
Changes in resistance training performance, rating of perceived exertion, and blood biomarkers after six weeks of supplementation with L-citrulline vs. L-citrulline DL-malate in resistance-trained men: a double-blind placebo-controlled trial.
Bayat D, Azizi M, Behpour N, Tinsley GM. Bayat D, et al. J Int Soc Sports Nutr. 2025 Dec;22(1):2513944. doi: 10.1080/15502783.2025.2513944. Epub 2025 Jun 5. J Int Soc Sports Nutr. 2025. PMID: 40470618 Free PMC article. Clinical Trial.

RESULTS: Comparing mean scores revealed a significant difference between LC and PL (p < 0.001) and between CM and PL (p = 0.026) for total upper body (the sum of BP and IP) RTF, but only a trend for difference between LC and PL (p = 0.070) for total lowe

…

RESULTS: Comparing mean scores revealed a significant difference between LC and PL (p < 0.001) and between CM and PL (p =

…
Efficacy of a Biodegradable Dressing Containing Tranexamic Acid for Prevention of Alveolar Osteitis: A Randomized Clinical Trial.
Sohrabi A, Bayat F, Amirfarhangi S, Golalipour S, Khodadadzadeh P, Khorshidi S. Sohrabi A, et al. J Contemp Dent Pract. 2024 Nov 1;25(11):1015-1021. doi: 10.5005/jp-journals-10024-3778. J Contemp Dent Pract. 2024. PMID: 39905606 Clinical Trial.
RESULTS: The incidence of AO was not significantly different between the two groups (7.6% in the experimental group and 8.9% in the control group, p = 0.744). The odds of AO development in patients with level II or III difficulty were 9.169 times the odds of AO in patients …
RESULTS: The incidence of AO was not significantly different between the two groups (7.6% in the experimental group and 8.9% in the control …
Anti-human neutrophil antigen-1d specificity is frequently observed in anti-human neutrophil antigen-1b alloantisera.
Grabowski C, Reil A, Bux J, Bayat B, Sachs UJ. Grabowski C, et al. Transfusion. 2022 Nov;62(11):2205-2211. doi: 10.1111/trf.17118. Epub 2022 Sep 29. Transfusion. 2022. PMID: 36173690
RESULTS: Three amino acids, p.36S, p.78A, and p.82N, are involved in epitope formation of HNA-1b. The following specificities were identified in 11 HNA-1b alloantisera: p.36S (6/11), p.82N (9/11), and p.78A&p.82N (8/11), of whi …
RESULTS: Three amino acids, p.36S, p.78A, and p.82N, are involved in epitope formation of HNA-1b. The following specifi …
Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study.
Uhlig T, Eskild T, Karoliussen LF, Sexton J, Kvien TK, Haavardsholm EA, Dalbeth N, Hammer HB. Uhlig T, et al. Rheumatology (Oxford). 2022 Apr 18;61(SI):SI81-SI85. doi: 10.1093/rheumatology/keab533. Rheumatology (Oxford). 2022. PMID: 34247224 Free PMC article.
Images were scored in known order, using the semi-quantitative Bayat method, by one experienced radiologist who was blinded to serum urate and clinical data. ...DECT scores at all locations decreased during both the first and the second year (P <0.001 for all com …
Images were scored in known order, using the semi-quantitative Bayat method, by one experienced radiologist who was blinded to serum …
The effect of DRD4 gene on violence tendency in athletes.
Ataş Ş, Ünver Ş, Aci R, Inaç Y, Atan AU, Yiğit S. Ataş Ş, et al. J Investig Med. 2025 Dec 3:10815589251406151. doi: 10.1177/10815589251406151. Online ahead of print. J Investig Med. 2025. PMID: 41339265

Our findings reveal significant differences in certain DRD4 variable number tandem repeat genotypes and alleles between athlete and sedentary groups, particularly in the 2/4 and 4/4 genotypes and the 2R and 4R alleles (p < 0.05), while no meaningful differences were obs

…
Our findings reveal significant differences in certain DRD4 variable number tandem repeat genotypes and alleles between athlete and sedentar …
The effect of patient-centered empowerment program through telenursing on self-management in people with multiple sclerosis: a double-blinded randomized clinical trial.
Bayat F, Negarandeh R, Pashaeypoor S. Bayat F, et al. BMC Neurol. 2025 Apr 2;25(1):138. doi: 10.1186/s12883-025-04148-x. BMC Neurol. 2025. PMID: 40175934 Free PMC article. Clinical Trial.
The results indicated no significant differences in the mean scores of self-management and its relevant subscales, between the two groups before the intervention (P > 0.05). However, after the intervention, the mean scores showed a significant difference in the interven …
The results indicated no significant differences in the mean scores of self-management and its relevant subscales, between the two groups be …
801 results